VistaGen Therapeutics, Inc. (VSTA) Utilizing Stem Cell Technology to Improve … – InvestorIdeas.com (press release)
|
VistaGen Therapeutics, Inc. (VSTA) Utilizing Stem Cell Technology to Improve …
InvestorIdeas.com (press release) The company's CardioSafe 3D™ technology utilizes VistaGen's human pluripotent stem cell-derived cardiomyocytes (hPSC-CM) and customized assays to screen for heart complications of new drug candidates, including cardiomyocyte cytotoxicity and the … |
